These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9637268)

  • 1. Immunohistochemical determination of tumor angiogenesis measured by the maximal microvessel density in human prostate cancer.
    Offersen BV; Borre M; Overgaard J
    APMIS; 1998 Apr; 106(4):463-9. PubMed ID: 9637268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of different vascular endothelial markers in prostate cancer and BPH tissue: an immunohistochemical and clinical evaluation.
    Trojan L; Thomas D; Friedrich D; Grobholz R; Knoll T; Alken P; Michel MS
    Anticancer Res; 2004; 24(3a):1651-6. PubMed ID: 15274336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome.
    Rubin MA; Buyyounouski M; Bagiella E; Sharir S; Neugut A; Benson M; de la Taille A; Katz AE; Olsson CA; Ennis RD
    Urology; 1999 Mar; 53(3):542-7. PubMed ID: 10096381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical localization of platelet-derived endothelial cell growth factor expression and its relation to angiogenesis in prostate.
    Okada K; Yokoyama K; Okihara K; Ukimura O; Kojima M; Miki T; Takamatsu T
    Urology; 2001 Feb; 57(2):376-81. PubMed ID: 11182368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waiting.
    Borre M; Nerstrøm B; Overgaard J
    Clin Cancer Res; 2000 May; 6(5):1882-90. PubMed ID: 10815911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Angiogenesis: prognostic marker in prostatic cancer].
    Borre M; Offersen IB; Nerstrøm B; Overgaard J
    Ugeskr Laeger; 1999 Jun; 161(25):3832-6. PubMed ID: 10412301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconsideration of the clinical and histopathological significance of angiogenesis in prostate cancer: Usefulness and limitations of microvessel density measurement.
    Miyata Y; Sakai H
    Int J Urol; 2015 Sep; 22(9):806-15. PubMed ID: 26153072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of microvessel density in prostate cancer: a tissue microarray study.
    Erbersdobler A; Isbarn H; Dix K; Steiner I; Schlomm T; Mirlacher M; Sauter G; Haese A
    World J Urol; 2010 Dec; 28(6):687-92. PubMed ID: 19714336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.
    Sinha AA; Quast BJ; Reddy PK; Lall V; Wilson MJ; Qian J; Bostwick DG
    Exp Mol Pathol; 2004 Oct; 77(2):153-9. PubMed ID: 15351240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor size, vascular density and proliferation as prognostic markers in GS 6 and GS 7 prostate tumors in patients with long follow-up and non-curative treatment.
    Josefsson A; Wikström P; Granfors T; Egevad L; Karlberg L; Stattin P; Bergh A
    Eur Urol; 2005 Oct; 48(4):577-83. PubMed ID: 15990221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvessel density as a predictor of PSA recurrence after radical prostatectomy. A comparison of CD34 and CD31.
    de la Taille A; Katz AE; Bagiella E; Buttyan R; Sharir S; Olsson CA; Burchardt T; Ennis RD; Rubin MA
    Am J Clin Pathol; 2000 Apr; 113(4):555-62. PubMed ID: 10761458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy.
    Hall MC; Troncoso P; Pollack A; Zhau HY; Zagars GK; Chung LW; von Eschenbach AC
    Urology; 1994 Dec; 44(6):869-75. PubMed ID: 7527168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer.
    Ekici S; Cerwinka WH; Duncan R; Gomez P; Civantos F; Soloway MS; Lokeshwar VB
    Int J Cancer; 2004 Oct; 112(1):121-9. PubMed ID: 15305383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvessel density, p53, retinoblastoma, and chromogranin A immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostate.
    Krupski T; Petroni GR; Frierson HF; Theodorescu JU
    Urology; 2000 May; 55(5):743-9. PubMed ID: 10792093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive values of vascular endothelial growth factor and microvessel-density levels in initial biopsy for prostate cancer.
    Kervancioglu E; Kosan M; Erinanc H; Gonulalan U; Oguzulgen AI; Coskun EZ; Ozkardes H
    Kaohsiung J Med Sci; 2016 Feb; 32(2):74-9. PubMed ID: 26944325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor angiogenesis as a prognostic factor in oral cavity carcinomas.
    López-Graniel CM; Tamez de León D; Meneses-García A; Gómez-Ruiz C; Frias-Mendivil M; Granados-García M; Barrera-Franco JL
    J Exp Clin Cancer Res; 2001 Dec; 20(4):463-8. PubMed ID: 11876537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting.
    Borre M; Offersen BV; Nerstrøm B; Overgaard J
    Br J Cancer; 1998 Oct; 78(7):940-4. PubMed ID: 9764587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial cell proliferation in prostatic carcinoma and prostatic hyperplasia: correlation with Gleason's score, microvessel density, and epithelial cell proliferation.
    Vartanian RK; Weidner N
    Lab Invest; 1995 Dec; 73(6):844-50. PubMed ID: 8558846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvessel quantification and its possible relation with liver metastasis in colorectal cancer.
    Tomisaki S; Ohno S; Ichiyoshi Y; Kuwano H; Maehara Y; Sugimachi K
    Cancer; 1996 Apr; 77(8 Suppl):1722-8. PubMed ID: 8608569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas.
    Siitonen SM; Haapasalo HK; Rantala IS; Helin HJ; Isola JJ
    Mod Pathol; 1995 Sep; 8(7):745-52. PubMed ID: 8539232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.